CHRISTINA LAFOON: Open Payments
NPI 1881120806 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 65 payments from 16 companies in 2025. Trend: 2023 $419 · 2024 $596 · 2025 $1,295
Food & beverage: $1,295
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $223 |
| Novartis Pharmaceuticals Corporation | 10 | $180 |
| E.R. Squibb & Sons, L.L.C. | 10 | $150 |
| Novo Nordisk Inc | 5 | $133 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| Boston Scientific Corporation | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $64 |
| PFIZER INC. | 3 | $53 |
| Merck Sharp & Dohme LLC | 3 | $47 |
Products named: LEQVIO, REPATHA, Wegovy, Kerendia, CAMZYOS, CDS - MCT/CEM Monitoring, ELIQUIS, LifeVest.
Industry payments across NC — which companies pay providers there.
